Skip to main content
Boditech Med Inc. logo

Boditech Med Inc. — Investor Relations & Filings

Ticker · 206640 ISIN · KR7206640005 KO Manufacturing
Open in API
Filings indexed 243 across all filing types
Latest filing 2024-08-13 Transaction in Own Shar…
Country KR South Korea
Listing KO 206640

About Boditech Med Inc.

https://www.boditech.co.kr/

Boditech Med Inc. is a company specializing in the development, manufacturing, and distribution of in-vitro diagnostic (IVD) solutions. The company focuses on key technologies in immunodiagnostics and molecular diagnostics to provide a range of diagnostic instruments and reagents. Its products are engineered to deliver reliable and accessible testing for various healthcare applications, from point-of-care to laboratory settings. The company's mission is to enhance the quality of life by providing advanced and dependable diagnostic tools to healthcare professionals worldwide.

Recent filings

Filing Released Lang Actions
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding a 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정). This filing specifically details the company's plan to dispose of its own shares, which falls under the category of 'Transaction in Own Shares'.
2024-08-13 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for Boditech Med, detailing quarterly financial highlights such as revenue, operating profit, and net income for Q2 2024. It is a standard initial announcement of financial results, which fits the definition of an Earnings Release (ER). Q2 2024
2024-08-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and their special relations (e.g., Choi Eui-yul and others). This type of filing is specifically used to notify the market and regulators of significant changes in shareholding percentages, which falls under the 'Major Shareholding Notification' category.
2024-06-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report insider transactions or changes in share ownership by company directors and executives. According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2024-05-14 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '바디텍메드(주)' (Boditech Med, Inc.) covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial information, business operations, management discussions, and financial statements, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Boditech Med, detailing quarterly financial highlights such as revenue, operating profit, and net income for Q1 2024. It is a standard regulatory disclosure of preliminary financial results, which fits the definition of an Earnings Release (ER). Q1 2024
2024-05-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.